Medical News
News 12/2008
Clinical results circumstantiate formoline’s effectiveness in anti-obesity treatment
Freiburg, Germany: The 24th annual meeting of the German Adiposity Society involved a satellite symposium, organized by our Medical Director Dr. I. Burkard. This has been formoline`s scientific highlight for Certmedica International GmbH in 2008. New results from our clinical studies were presented by important opinion leaders:
The main findings were as follows:
- The clinical efficacy of metformin treatment in diabetes was not clinically affected by formoline L112.
- Both concepts, the formula diets and the lipid binders (like formoline protein diet and L112) proved to have statistically significant effects in weight reduction.
- The combination therapy of formoline protein diet plus formoline L112 enhances results in weight reduction even more, as moreover the bio impedance analyses shows a weight loss of more than 6 kg fat of the patients, during the 20-weeks-treatment-phase
More than 120 physicians visited the meeting and afterwards many people came to our booth to taste the formoline protein diet powder`s flavor, mixed in various tasty drinks, yoghurts etc.
Prof. Alfred Wirth, Chief Physician, Bad Rothenfelde, former President of the German Adiposity Society;
Prof. Burkhard Weisser, Director of the Institute of Sport and Exercise Science;
(ISES) Christian-Albrechts-University to Kiel, President of the SELF IS;
Prof. Udo Rabast, Chief Physician Niederwenigern, Hattingen